Your browser doesn't support javascript.
loading
Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer.
Toppmeyer, Deborah L; Press, Michael F.
Affiliation
  • Toppmeyer DL; Department of Medicine, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Press MF; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Cancer Med ; 9(18): 6463-6472, 2020 09.
Article in En | MEDLINE | ID: mdl-32697890
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / DNA Mutational Analysis / Biomarkers, Tumor / Class I Phosphatidylinositol 3-Kinases / Mutation Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / DNA Mutational Analysis / Biomarkers, Tumor / Class I Phosphatidylinositol 3-Kinases / Mutation Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country: Country of publication: